End-to-end imaging execution powered by ONIX AI, combining intelligent workflows with clinician-led delivery for faster, audit-ready trials.
The result is a predictable set of failure modes that affect every sponsor running a trial today.
Legacy iCROs often require 4–8 weeks for site activation. GenPhase is designed to enable significantly faster study setup, targeting activation within days.
Protocol deviations are often identified only after reads are completed. Most workflows lack early-stage validation before case assignment.
Outputs are often delivered as PDFs, requiring manual transcription into eCRF systems. This creates inefficiencies and increases the risk of data inconsistencies.
Traditional onshore-only delivery models can lead to higher per-read costs. A hybrid delivery approach offers an opportunity to improve cost efficiency without compromising quality.
Disconnected systems can create gaps in auditability during regulatory review. A unified, traceable event chain is increasingly critical for inspection readiness.
We are not asking you to adopt a platform. We are asking you to subcontract imaging execution: structured deliverables, on time, with a clean audit trail.
See CRO ServicesYou're building a pipeline drug, not an imaging operation. We handle the entire imaging layer — from study setup to final read.
See Biopharma ServicesONIX AI™ is the read surface — not an AI layer bolted onto someone else's viewer. Protocol-driven workflows, intelligent case routing, and multi-reader adjudication — supported by a full 21 CFR Part 11 audit trail and human-in-the-loop governance at every step.
Seasoned executives and credentialed clinicians united by a passion for compliant, scalable clinical imaging delivery.
Chief Executive Officer
Chief Technology Officer
Clinical Advisor
Clinical Advisor
Thought leadership from our clinical and technical team on imaging compliance, iCRO operations, and regulated research technology.
As clinical trials become more complex and competitive, the role of medical imaging has never been more critical. If you’re experiencing any of these five red flags, it may be time to re-evaluate your imaging strategy.
Read More
Clinical research is becoming increasingly data-intensive and operationally complex. Medical imaging is playing a growing role in evaluating treatment efficacy, monitoring safety, and supporting regulatory submissions across a wide range of therapeutic areas.
Read MoreOur clinical team typically responds within one business day. No automated sequences. A real person who knows clinical imaging.
1990 N California Blvd., 8th Floor
Walnut Creek, CA 94596
(844) 922-7468
hello@genphase.ai
Fill out the form and a member of our clinical team will respond within one business day.
By submitting this form, you agree to let GenPhase use the information provided to send relevant content about our products and services. You can unsubscribe at any time.
The modern alternative to legacy imaging CROs.
Built for the teams changing medicine.